4.8 Article

Synthesis of Chiral Spirolactams via Sequential C-H Olefination/Asymmetric [4+1] Spirocyclization under a Simple CoII/Chiral Spiro Phosphoric Acid Binary System

Journal

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 60, Issue 43, Pages 23187-23192

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.202108853

Keywords

binary catalysts; C-H activation; chiral phosphoric acid; cobalt; enantioselectivity

Funding

  1. National Natural Science Foundation of China [21925109, 21772170]
  2. China Postdoctoral Science Foundation [2020M671691]
  3. Center of Chemistry for Frontier Technologies of Zhejiang University
  4. Open Research Fund of School of Chemistry and Chemical Engineering of Henan Normal University

Ask authors/readers for more resources

An unprecedented enantioselective synthesis of spiro-gamma-lactams was achieved using a simple Co-II/chiral spiro phosphoric acid binary system, resulting in high levels of enantioselectivity. Additionally, a concise synthesis of an aldose reductase inhibitor was successfully carried out under this system.
An unprecedented enantioselective synthesis of spiro-gamma-lactams via a sequential C-H olefination/asymmetric [4+1] spirocyclization under a simple Co-II/chiral spiro phosphoric acid (SPA) binary system is reported. A range of biologically important spiro-gamma-lactams are obtained with high levels of enantioselectivity (up to 98 % ee). The concise, asymmetric synthesis of an aldose reductase inhibitor was successfully achieved. Notably, contrast to previous reports that relied on the use of cyclopentadienyl or its derivatives (achiral Cp*, Cp-tBu, or chiral Cp-x) ligated Co-III complexes requiring tedious steps to prepare, cheap and commercially available cobalt(II) acetate tetrahydrate was used as an efficient precatalyst.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available